Emergent BioSolutions (EBS) Interest Coverage Ratio (2011 - 2026)
Emergent BioSolutions (EBS) posted quarterly Interest Coverage Ratio of 0.8 for Q1 2026, down 73.18% year-over-year from 2.99 in Q1 2025, and up 142.23% quarter-over-quarter from 1.9 in Q4 2025.
Emergent BioSolutions (EBS) Interest Coverage Ratio (2011 - 2026) Analysis & Trends
Emergent BioSolutions' Interest Coverage Ratio history runs 16 years deep, the most recent figure standing at 0.8 for Q1 2026.
- In Q1 2026, Interest Coverage Ratio fell 73.18% year-over-year to 0.8; the TTM figure through Mar 2026 stood at 1.02 (up 158.16% YoY), while the FY2025 annual figure was 0.3, up 194.71% from the prior year.
- Interest Coverage Ratio for Q1 2026 stood at 0.8, up from 1.9 in the prior quarter.
- The five-year high for Interest Coverage Ratio was 7.77 in Q3 2024, with the low at 12.29 in Q3 2023.
- The 5-year median for Interest Coverage Ratio is 1.9 (2025), against an average of 2.62.
- The sharpest annual moves came in 2022 and 2024: Interest Coverage Ratio sank 1284.87% in 2022, then surged 163.23% in 2024.
- Emergent BioSolutions' Interest Coverage Ratio stood at 5.22 in 2022, then surged by 61.31% to 2.02 in 2023, then jumped by 39.66% to 1.22 in 2024, then tumbled by 55.83% to 1.9 in 2025, then jumped by 142.23% to 0.8 in 2026.
- Business Quant data shows EBS's Interest Coverage Ratio at 0.8 in Q1 2026, 1.9 in Q4 2025, and 5.03 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -3.15 |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 114.07 |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 0.05 |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 52.24 |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 4.20 |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Emergent BioSolutions | 251.81 Mn | 110.91 Mn | 137.20 Mn | -12.51 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -12.51 |
| Mar 31, 2026 | 0.80 |
| Dec 31, 2025 | -1.90 |
| Sep 30, 2025 | 5.03 |
| Jun 30, 2025 | 0.05 |
| Mar 31, 2025 | 2.99 |
| Dec 31, 2024 | -1.22 |
| Sep 30, 2024 | 7.77 |
| Jun 30, 2024 | -8.62 |
| Mar 31, 2024 | 1.64 |
| Dec 31, 2023 | -2.02 |
| Sep 30, 2023 | -12.29 |
| Jun 30, 2023 | -10.24 |
| Mar 31, 2023 | -6.83 |
| Dec 31, 2022 | -5.22 |
| Sep 30, 2022 | -5.33 |
| Jun 30, 2022 | -9.78 |
| Mar 31, 2022 | 0.59 |
| Dec 31, 2021 | 39.83 |
| Sep 30, 2021 | -5.32 |